The recent outbreak of the coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) in the last few months raised global health concern. Previous research described that remdesivir and ritonavir can be used as effective drugs against COVID-19. In this study, we applied the structure-based virtual screening (SBVS) on the high similar remdesivir- and ritonavir-approved drugs, selected from the DrugBank database as well as on a series of ritonavir derivatives, selected from the literature. The aim was to provide new potent SARS-CoV-2 main protease (Mpro) inhibitors with high stability. The analysis was performed using AutoDock VINA implicated in the PyRx 0.8 tool. Based on the ligand binding energy, 20 compounds were selected and then analyzed by AutoDock tools. Among the 20 compounds, 3 compounds were selected as high-potent anti-COVID-19.
Photocatalytic activity of (50-x/2)Na2O-xTiO2–(50-x/)P2O5 glasses (0 ≤ x ≤ 10 mol%) has been studied with an increase in the TiO2 content using UV-Visible spectrophotometry. Thermal properties were carried out from DTA measurement, and the variation of glass structure was investigated by Fourier Transform Infrared (FT-IR). The first addition of the TiO2 up to 3 mol% entrained depolymerization of the phosphate skeleton (PO3) chains in the binary 50Na2O–50P2O5 glass, resulting in poor cross-linking, which in turn the glass network becomes less rigid and the glass transition temperature (Tg) was decreased. Beyond this value, FT-IR reveals the formation of P–O–Ti bonds, which increases the cross-link density in the glass network and therefore increases Tg of the glasses. The photocatalytic activity results showed that these glasses ensure the discoloration of Rhodamine B by a removal efficiency of about 94% after 4h of irradiation.